| Issue |
BIO Web Conf.
Volume 22, 2020
International Conference “Longevity Interventions 2020” (ICLI 2020)
|
|
|---|---|---|
| Article Number | 01021 | |
| Number of page(s) | 9 | |
| Section | Problems of Gerontology and Geriatrics | |
| DOI | https://doi.org/10.1051/bioconf/20202201021 | |
| Published online | 06 July 2020 | |
Syndrome of perimenopausal melatonin deficiency is a new marker of women reproductive system aging
1
State Budgetary Health Instution “Regional Clinical Hospital N 3”, Ministry of Health of the Russian Federation, Russia
2
Federal State Budgetary Educational Institution of Higher Education “South-Ural State Medical University” of the Ministry of Healthcare of the Russian Federation University, 454092, Vorovskogo Str., 64, Chelyabinsk, Russia
3
Federal State Budgetary Educational Institution of Higher Education “Northern State Medical University” of the Ministry of Healthcare of the Russian Federation University, 163000, Troitskiy Ave., 51, Arkhangelsk, Russia
* Corresponding author: Alexandramamontova@rambler.ru
** Corresponding author: Elena-usoltseva@yandex.ru
*** Corresponding author: ASoloviev1@yandex.ru
The aim of our study was to determine a complex of risk factors of the perimenopausal melatonin deficiency syndrome (SPDM) in postmenopausal women and women during menopausal transition suffering from climacteric syndrome. The study involved 278 women. They were divided into two groups: I group included 246 menopausal women and II group included 32 women during the menopausal transition. The Medical History was collected, the menopausal index, and anthropometric measures were determined. The study was conducted with a help of the test questionnaire for melatonin deficiency (TQMD), the women’s health questionnaire (WHQ), and detection of the level of 6- sulfatoxymelatonin (6-SOMT) in urine. According to the obtained data, risk factors of SPDM in women during the menopausal transition are the chronological age increment, overweight, and the reduction of the estradiol level. The leading risk factors of SPDM in postmenopausal women are the chronological age increment, overweight with visceral type of obesity and changes in the hormonal profile. Thus, SPDM is a new clinical and laboratory marker of aging of the female reproductive system, an important screening tool for detecting the development of CC in women during the menopausal transition and menopausal women.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.